<?xml version="1.0" encoding="iso-8859-1"?>
<rss version="2.0">
  <channel>
    <title>RSS News Feed for Microbix Biosystems - from Laboratorytalk</title>
    <link>http://www.laboratorytalk.com/news/mcr/mcr000.html</link>
    <description>Microbix Biosystems news releases on Laboratorytalk</description>
    <language>en-gb</language>
    <copyright>Copyright (C)2008 Pro-Talk Ltd. All rights reserved.</copyright>
    <pubDate>Tue, 10 Jun 2008 08:00:00 UT</pubDate>
    <lastBuildDate>Tue, 10 Jun 2008 08:00:00 UT</lastBuildDate>
    <image>
      <title>Pro-Talk Ltd</title>
      <url>http://www.pro-talk.com/images/protalklogo90.gif</url>
      <link>http://www.pro-talk.com/</link>
      <width>90</width>
      <height>79</height>
    </image>
    <item>
      <title>Microbix announces changes to board of directors</title>
      <description>Vaughn Embro-Pantalony has been appointed to the board of directors, replacing James A Long who has assumed his duties as chief financial officer, and has resigned as a director</description>
      <pubDate>Thu, 15 Feb 2007 08:00:00 UT</pubDate>
      <category>Microbix Biosystems</category>
      <link>http://www.laboratorytalk.com/news/mcr/mcr111.html</link>
    </item>
    <item>
      <title>Semen-sexing system has market potential</title>
      <description>Technology can separate male-producing sperm from female-producing sperm, thus ensuring the desired sex of offspring for use in commercial cattle and swine livestock production</description>
      <pubDate>Wed, 05 Oct 2005 08:00:00 UT</pubDate>
      <category>Microbix Biosystems</category>
      <link>http://www.laboratorytalk.com/news/mcr/mcr110.html</link>
    </item>
    <item>
      <title>Flu technology attracts interest</title>
      <description>Microbix enters exclusive review and negotiation period for proprietary influenza virus yield enhancement technology</description>
      <pubDate>Wed, 23 Jun 2004 08:00:00 UT</pubDate>
      <category>Microbix Biosystems</category>
      <link>http://www.laboratorytalk.com/news/mcr/mcr109.html</link>
    </item>
    <item>
      <title>Patent filed for new vaccine technology platform</title>
      <description>New proprietary vaccine technology platform is said to have the potential to offer significant economic advantages to vaccine producers</description>
      <pubDate>Wed, 02 Jul 2003 08:00:00 UT</pubDate>
      <category>Microbix Biosystems</category>
      <link>http://www.laboratorytalk.com/news/mcr/mcr108.html</link>
    </item>
    <item>
      <title>Microbix raises financing to continue development</title>
      <description>Microbix Biosystems has announced that it has completed a Canadian $500,000 Principal amount 8% convertible debenture, in a non-arms length transaction with an existing shareholder.</description>
      <pubDate>Tue, 24 Dec 2002 08:00:00 UT</pubDate>
      <category>Microbix Biosystems</category>
      <link>http://www.laboratorytalk.com/news/mcr/mcr107.html</link>
    </item>
    <item>
      <title>Mystery partner in urokinase deal</title>
      <description>Generic version of Abbott's urokinase drug Abbokinase, for the treatment of pulmonary embolism or lung blood clots, to be developed in agreement with secretive partner</description>
      <pubDate>Fri, 22 Nov 2002 08:00:00 UT</pubDate>
      <category>Microbix Biosystems</category>
      <link>http://www.laboratorytalk.com/news/mcr/mcr106.html</link>
    </item>
    <item>
      <title>Agreement on adenovirus vector technology</title>
      <description>Helper-dependent (HD) adenovirus vectors are being studied at the basic research level as potential tools for gene therapy and drug delivery</description>
      <pubDate>Tue, 19 Nov 2002 08:00:00 UT</pubDate>
      <category>Microbix Biosystems</category>
      <link>http://www.laboratorytalk.com/news/mcr/mcr105.html</link>
    </item>
    <item>
      <title>Successful third quarter</title>
      <description>Microbix Biosystems reports profitable third quarter and 19% rise in sales</description>
      <pubDate>Fri, 30 Aug 2002 08:00:00 UT</pubDate>
      <category>Microbix Biosystems</category>
      <link>http://www.laboratorytalk.com/news/mcr/mcr104.html</link>
    </item>
    <item>
      <title>Biotech exec joins the board</title>
      <description>Microbix biosystems announces the addition of a biotechnology executive Patrick Walsh to its board of directors</description>
      <pubDate>Fri, 02 Aug 2002 08:00:00 UT</pubDate>
      <category>Microbix Biosystems</category>
      <link>http://www.laboratorytalk.com/news/mcr/mcr103.html</link>
    </item>
    <item>
      <title>New York panel on generic biologics</title>
      <description>Generic Pharmaceutical Association's workshop on regulatory and legislative issues hears industry views on characterisation of active pharmaceutical ingredients</description>
      <pubDate>Fri, 22 Mar 2002 08:00:00 UT</pubDate>
      <category>Microbix Biosystems</category>
      <link>http://www.laboratorytalk.com/news/mcr/mcr102.html</link>
    </item>
    <item>
      <title>Microbix on generic biologics panel</title>
      <description>Microbix Biosystems will participate in a four-member FDA-sponsored panel to address issues of comparability and equivalence at the 6th WCBP Symposium in Washington</description>
      <pubDate>Tue, 05 Feb 2002 08:00:00 UT</pubDate>
      <category>Microbix Biosystems</category>
      <link>http://www.laboratorytalk.com/news/mcr/mcr101.html</link>
    </item>
    <item>
      <title>TransAtlantic cell evolution</title>
      <description>Nautilus Biotech of France and Microbix Biosystems of Canada announce a distribution agreement for academic applications of NautCell, a high-producer cell-line for recombinant Adeno-associated vectors</description>
      <pubDate>Wed, 30 Jan 2002 08:00:00 UT</pubDate>
      <category>Microbix Biosystems</category>
      <link>http://www.laboratorytalk.com/news/mcr/mcr100.html</link>
    </item>
  </channel>
</rss>
